REYON Pharmaceutical Co., Ltd. (KRX:102460)

Market Cap	201.20B
Revenue (ttm)	148.04B
Net Income (ttm)	4.04B
Shares Out	18.34M
EPS (ttm)	220.34
PE Ratio	49.79
Forward PE	n/a
Dividend	150.00 (1.37%)
Ex-Dividend Date	n/a

Volume	8,731
Average Volume	11,931
Open	11,100
Previous Close	10,980
Day's Range	10,950 - 11,120
52-Week Range	9,830 - 18,650
Beta	0.68
RSI	50.35
Earnings Date	May 14, 2025

About REYON Pharmaceutical

REYON Pharmaceutical Co., Ltd. manufactures and sells medicines. The company offers its products under the areas of adrenal corticosteroides; angiotensin II receptor antagonists; antibiotics; anticholinergics; antiemetic; antihypertensives; anti-inflammatory enzymes; antilipidemic, antirheumatic, and oral hypoglycemic agents; anti-peptic ulcer; antispasmodics; benign prostatic hypertrophy; cough and cold remedies; cardiac stimulant; genitourinary smooth muscle relaxants; hemostatics; immunosuppressants; rheumatoid arthritis; local anesthetics; ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1955
• Employees: 448
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 102460

Financial Performance

In 2024, REYON Pharmaceutical's revenue was 148.30 billion, a decrease of -1.83% compared to the previous year's 151.07 billion. Earnings were 4.15 billion, an increase of 15.85%.